SOLID BIOSCIENCES INC. — Income Charts
6 years of history · ending 2022-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$8M
R&D↑+35.3% +$20M
$78M
D&A↑+53.8% +$842K
$2M
Operating Income↓-40.6% -$31M
$-106M
EBITDA↓-40.4% -$30M
$-104M
Interest Expense
—
Interest Income↑+322.6% +$2M
$3M
Other Income/Expense
—
Pretax Income
—
Tax Provision
$0
Net Income↓-15.0% -$11M
$-86M
Operating Margin
-1315.2%
Net Margin
-1062.3%
Effective Tax Rate
—
Deferred Tax Liabilities
$8M
DTA Valuation Allowance↑+547.7% +$138M
$164M
Tax Credit Carryforwards↑+577.8% +$40M
$47M
NOL Carryforwards↑+332.3% +$55M
$71M
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+1.9pts
7.4%
Operating Lease Cost
—
Revenue YoY Variation
-40.6%
Income YoY Variation↓-9.4pts
-47.3%